SLS Europe team, together with Serum Institute of India Pvt. Ltd., presented our leading TB vaccine, VPM1002, contributing to global discussions on TB vaccine innovation.
Active engagement and collaboration with global leaders enriched the dialogue on advancing TB vaccine research. The symposium served as a platform for networking and pushing the boundaries of innovation in TB research.
A special thanks to TuBerculosis Vaccine Initiative (TBVI) for the organization of this pivotal event. Looking forward to the next meeting and continued collaboration!